The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TBC Moderna Australia Pty Ltd
Product name
TBC
Sponsor
Accepted date
Jan-2025
Active ingredients
SARS-CoV-2 spike NTD-RBD mRNA
Proposed indication
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus in persons 12 years of age and older.
Application type
A (new medicine)
Publication date
Jan-2025